K Number
K211250
Date Cleared
2021-06-21

(56 days)

Product Code
Regulation Number
876.1500
Reference & Predicate Devices
Predicate For
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The VisionPort System is intended to be used in diagnostic and therapeutic for endoscopic surgery within the thoracic and peritoneal cavities including the female reproductive organs to establish a path of entry for endoscopic instruments and to provide an image of the surgical field. The trocar may be used with or without visualization for primary and secondary insertions.

Device Description

The VisionPort System consists of an access port with an integrated camera and light source, the handpiece, a wired control pad to control the camera functions, and a control unit, specifically:

    1. VisionPort System Handpiece single use
    • HD camera and lighting module a.
    • b. 12.9mm internal diameter access port with 5-12mm instrument seal
    • Lens cleaning system (saline wash and wiper blade) C.
    • d. Connections for saline wash source and insufflation tubing
    • e. Removable obturator designed for visible entry
    1. VisionPort System Control Pad single use
    • a. Camera control functions (zoom, pan)
    • b. Light emitting diode (LED) adjustment
    • c. Image capture and display control buttons
    1. VisionPort System Control Unit
    • a. System power
    • b. Image processing (no patient data recording or retention)
    • Outputs to operating room monitor(s) and/or third-party Data Control Unit (for image C. capture and printing options)
AI/ML Overview

The provided text describes the VisionPort System, an endoscopic surgical device, and its substantial equivalence to predicate devices, but it does not contain information about acceptance criteria or a study proving that the device meets those criteria in the context of an AI/ML-assisted medical device.

The document is a 510(k) summary for a medical device (VisionPort System) to establish substantial equivalence with existing predicate devices. It focuses on the device's design, indications for use, and a comparison of its technological characteristics with predicate devices.

While it mentions "performance data" and "functional testing" to verify that the device met "all design specifications" and "acceptance criteria," these are general statements about the device's functionality rather than specific, quantitative acceptance criteria for an AI/ML component. The "functional testing" appears to be related to the physical and operational aspects of the endoscope and its components, referencing standards like ISO 8600.

Therefore, I cannot provide the requested information regarding acceptance criteria and a study proving an AI/ML component meets those criteria, as the document does not discuss such an AI/ML feature as part of the VisionPort System.

Here's why the requested information cannot be extracted from the provided text:

  • No AI/ML Component: The device description and comparisons do not indicate the presence of artificial intelligence or machine learning components within the VisionPort System. It's an endoscopic system with a camera, light source, control pad, and control unit.
  • No Quantitative Acceptance Criteria for AI/ML: Since there's no mention of an AI/ML component, there are no specific quantitative acceptance criteria (like sensitivity, specificity, AUC) for such a component.
  • No Study Design for AI/ML Performance: Consequently, there is no study described that would prove an AI/ML component meets acceptance criteria. The performance data section refers to sterilization, biocompatibility, electrical safety, EMC, and functional testing of the physical device.

In summary, the provided document does not align with the premise of the question, which assumes an AI/ML-assisted medical device.

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food & Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo is in blue and includes the letters "FDA" in a square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in a sans-serif font.

June 21, 2021

New View Surgical, Inc. % Maureen O'Connell President O'Connell Regulatory Consultant, Inc. 44 Oak Street Stoneham, Massachusetts 02180

Re: K211250

Trade/Device Name: VisionPort System Regulation Number: 21 CFR 876.1500 Regulation Name: Endoscope And Accessories Regulatory Class: Class II Product Code: GCJ, HET Dated: April 23, 2021 Received: April 26, 2021

Dear Maureen O'Connell:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrl/cfdocs/cfpmn/pmn.cfm identifies.combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{1}------------------------------------------------

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531 -542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely.

Long Chen, Ph.D. Assistant Director DHT4A: Division of General Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known)

K211250

Device Name VisionPort™ System

Indications for Use (Describe)

The VisionPort System is intended to be used in diagnostic and therapeutic for endoscopic surgery within the thoracic and peritoneal cavities including the female reproductive organs to establish a path of entry for endoscopic instruments and to provide an image of the surgical field. The trocar may be used with or without visualization for primary and secondary insertions.

Type of Use (Select one or both, as applicable)

|X Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

510(k) SUMMARY

(K211250)

New View Surgical, Inc. VisionPort System

SUBMITTER

New View Surgical, Inc. 555 Massachusetts Ave. Ste. 5 Boston, MA 02118

Submission Correspondent

Maureen O'Connell O'Connell Regulatory Consultants, Inc. 44 Oak Street Stoneham. MA 02180 Phone: 978-207-1245

Date Prepared: June 2, 2021

DEVICE

Trade Name of Device: VisionPort System Common or Usual Name: Laparoscope Classification Name(s): Laparoscope, General & Plastic Surgery; 21 C.F.R. §876.1500 and Laparoscope, Gynecologic (and Accessories); 21 C.F.R. §884.1720 Regulatory Class: II Product Code(s): GCJ and HET

PREDICATE DEVICE(S)

Primary: Xenocor Xenoscope Laparoscopic System cleared in K161838 ENDOPATH XCEL Bladeless Trocar cleared in K122511 Secondary:

DEVICE DESCRIPTION

The VisionPort System consists of an access port with an integrated camera and light source, the handpiece, a wired control pad to control the camera functions, and a control unit, specifically:

    1. VisionPort System Handpiece single use
    • HD camera and lighting module a.
    • b. 12.9mm internal diameter access port with 5-12mm instrument seal
    • Lens cleaning system (saline wash and wiper blade) C.
    • d. Connections for saline wash source and insufflation tubing
    • e. Removable obturator designed for visible entry
    1. VisionPort System Control Pad single use
    • a. Camera control functions (zoom, pan)

{4}------------------------------------------------

  • b. Light emitting diode (LED) adjustment
  • c. Image capture and display control buttons
    1. VisionPort System Control Unit
    • a. System power
    • b. Image processing (no patient data recording or retention)
    • Outputs to operating room monitor(s) and/or third-party Data Control Unit (for image C. capture and printing options)

INDICATIONS FOR USE

The VisionPort System is intended to be used in diagnostic and therapeutic procedures for endoscopic surgery within the thoracic and peritoneal cavities including the female reproductive organs to establish a path of entry for endoscopic instruments and to provide an image of the surgical field. The trocar may be used with or without visualization for primary and secondary insertions.

SUBSTANTIAL EQUIVALENCE

The VisionPort System described in this notification and for use under the conditions of the proposed labeling is substantially equivalent to a legally marketed predicate device that is a Class II medical device. The VisionPort System is substantially equivalent to the Xenosope Laparoscopic System cleared in K161838 and a secondary predicate device, the ENDOPATH XCEL Bladeless Trocar cleared in K122511. A comparison to the primary predicate device is provided in Table 1 and to the secondary predicate device in Table 2. The combined intended use of the primary predicate and secondary predicate is the same as the intended use of the VisionPort System.

VisionPort System Substantial Equivalence: Primary Predicate Device
CharacteristicVisionPort SystemXenocor XenoscopeLaparoscopic System
510(k) NumberK211250K161838/K171344
Product CodeGCJ, HETGCJ, HET
Indications for UseIntended to be used indiagnostic and therapeuticprocedures for endoscopicsurgery within the thoracicand peritoneal cavitiesincluding the femalereproductive organs toestablish a path of entry forendoscopic instruments andto provide an image of thesurgical field. The trocar maybe used with or withoutvisualization for primary andsecondary insertions.Intended to be used in diagnosticand therapeutic procedures forendoscopy and endoscopicsurgery within the thoracic andperitoneal cavities including thefemale reproductive organs.
Clearance TypePrescriptionPrescription
UserHealthcare ProfessionalHealthcare Professional
Where UsedHospital, Surgery CenterHospital, Surgery Center
System DescriptionThe system includes the following components:-VisionPort SystemHandpiece-VisionPort System Control Pad-VisionPort System Control UnitThe system includes the following components:-Xenoscope Laparoscope Device-Xenoscope Dongle
ComponentComparisonVisionPort SystemHandpieceXenoscope Laparoscope
Image SensorCMOSCMOS
Lens
LEDs21
Video ImageHigh-definition videoHigh-definition video
Image TransferVideo cable from camera/scope to Control UnitVideo cable from camera/scope to Control Unit (Dongle)
Placement intoBody CavityIncorporates an access port/trocarInserted through an access port/trocar
Lens CleaningIncorporates a lens cleaning system (saline flush and wiper)No lens cleaning system
Camera FocusFixed FocusManual Focus
Camera ZoomElectronic ZoomManual Zoom
Camera LightLight (LED) AttenuationLight (LED) Attenuation
Camera MonitorMonitor Display ControlMonitor Display Control
Camera ImageCapture RelayImage Capture Relay using third party image capture systemNA
SterilitySingle use sterileSingle use sterile
ComponentComparisonVisionPort System Control UnitXenoscope Dongle
UseMulti-useMulti-use
Image TransferfromCamera/Scope toControl UnitVideo CableMicro-HDMI
Image Transferfrom Control Unitto MonitorDVIHDMI v1.3
USB2.0 service port (manufacturing)3.0 service port (manufacturing)
StandardsCompliance
Electrical SafetyPer IEC 60601-1Per IEC 60601-1
EMCPer IEC 60601-1-2Per IEC 60601-1-2
BiocompatibilityPer ISO 10993-1Per ISO 10993-1

Table 1 VisionPort System Sub ce

{5}------------------------------------------------

CharacteristicVisionPort SystemENDOPATH XCEL BladelessTrocar with OPTIVIEWTechnology
510(k) NumberK211250K122511

{6}------------------------------------------------

Product CodeGCJ, HETGCJ
Indications forUseIntended to be used indiagnostic and therapeuticprocedures for endoscopicsurgery within the thoracic andperitoneal cavities including thefemale reproductive organs toestablish a path of entry forendoscopic instruments and toprovide an image of thesurgical field. The trocar maybe used with or withoutvisualization for primary andsecondary insertions.Has applications in abdominal,thoracic, and gynecologicalminimally invasive surgicalprocedures to establish a path ofentry for endoscopic instruments.The trocar may be used with orwithout visualization for primaryand secondary insertions.
Clearance TypePrescriptionPrescription
UserHealthcare ProfessionalHealthcare Professional
Where UsedHospital, Surgery CenterHospital, Surgery Center
ComponentsSleeve and obturatorSleeve and obturator
Cannula Length100 mm100 mm
Cannula InnerDiameter12.9 mm12.9 mm
Cannula OuterDiameter17.8 mm15.5 mm
Endoscopic ViewIncorporates a 0-degreeendoscopic view of the trocartip and provides visibility ofindividual tissue layers duringinsertion using an imagecapture chip, light source andmirrorAccommodates a 0-degree or 30-degree endoscope to view thetrocar tip and provides visibilityof individual tissue layers duringinsertion.
Seal SystemThe sleeve has a two-sealsystem for maintainingpneumoperitoneum. The trocarsleeves contain two seals, anouter integrated non-removableself-adjusting seal thataccommodates instrumentsranging from 5 to 12 mm indiameter and an internal seal.The sleeve has an integrated two-seal system for maintainingpneumoperitoneum. The trocarsleeves contain two seals, anouter integrated removable self-adjusting seal that accommodatesinstruments ranging from 5 to 12mm in diameter and an internalseal.
StopcocksThe sleeve has two weldedstopcocks on the side of thecannula assembly, bothcompatible with standard luerlock fittings which provide forattachment of insufflationtubing and a saline flush forlens cleaning.The sleeve has one weldedstopcock assembly, which iscompatible with a standard luerlock fitting which provides forattachment of insufflation tubing.
Stability ThreadsSleeve cannula containsintegrated stability threads forSleeve cannula containsintegrated stability threads for

The VisionPort System has the same technological characteristics as the combination of the primary and secondary predicate devices. The different technological characteristics of the

{7}------------------------------------------------

devices do not raise different questions of safety and effectiveness. Performance data is provided which supports substantial equivalence.

PERFORMANCE DATA

Non-clinical testing was performed to verify that the proposed device met all design specifications and is substantially equivalent to the predicate device.

Sterilization and Shelf Life

Sterilization validation was performed as described in ISO 11135:2014, Sterilization of healthcare products -Ethylene oxide - Requirements for the development. validation and routine control of a sterilization process for medical devices. The sterilization assurance level (SAL) is 10-6.

Testing of EtO residuals was conducted per ISO 10993-7 Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals. VisionPort System Handpiece samples met the requirements of the standard.

Testing of package seal strength was performed in accordance with ASTM F88 - Standard Test Method for Seal Strength of Flexible Barrier Materials. All samples demonstrated a seal strength greater than 1.0 lbf/in specification. Visual inspection shows that all seals met specifications with no anomalies noted. The shelf life is confirmed by age testing both accelerated and real time in accordance with ASTM 1980-02. Reference Standard Guide for Accelerated Aging of Sterile Medical Device Packages.

Biocompatibility Testing

The materials used for the VisionPort System comply with biocompatibility requirements outlined in ISO 10993-1:2009 and the Guidance for Industry and Food and Drug Administration Staff, Use of International Standard ISO 10993 Biological Evaluation of Medical Devices Part 1: Evaluation and Testing within a Risk Management Process and are considered to be biocompatible. The contact type of the VisionPort System is: external communicating, tissue contact with limited contact duration and testing was provided to show compliance with ISO 10993-1. The battery of tests included:

  • . Cytotoxicity
  • . Sensitization
  • Intracutaneous Irritation
  • Systemic Toxicity ●
  • . Pyrogenicity

Electrical safety and electromagnetic compatibility (EMC)

The VisionPort System was tested for electrical safety and found to be in compliance with IEC 60601-1. IEC 60601-1-6. IEC 62366-1 and IEC 60601-2-18, and for electromagnetic compatibility to IEC 60601-1-2.

Functional Testing

Testing was performed to verify that the VisionPort Handpiece functions as intended:

{8}------------------------------------------------

  • When tested in accordance with ISO 8600-1 through ISO 8600-6. All test results met . acceptance criteria and were performed in accordance ISO 8600.
  • In accordance with design input requirements. The test data demonstrates that the ● VisionPort System functions as intended and in accordance with design input requirements.

Testing was provided which compared performance of the VisionPort System compared to the secondary predicate device (ENDOPATH® XCEL® Bladeless Trocar with OPTIVIEW Technology (K122511)) and to document substantial equivalence in performance related to recommended use. The testing showed that the VisionPort System can be operated in simulated use conditions when used in accordance with the Manual and IFU and is equivalent to the predicate systems for the attributes tested in this protocol.

CONCLUSIONS

The performance data supports the safety of the device and shows that the device performs as intended. The substantial equivalence discussion supports the finding of substantial equivalence to the predicate devices.

§ 876.1500 Endoscope and accessories.

(a)
Identification. An endoscope and accessories is a device used to provide access, illumination, and allow observation or manipulation of body cavities, hollow organs, and canals. The device consists of various rigid or flexible instruments that are inserted into body spaces and may include an optical system for conveying an image to the user's eye and their accessories may assist in gaining access or increase the versatility and augment the capabilities of the devices. Examples of devices that are within this generic type of device include cleaning accessories for endoscopes, photographic accessories for endoscopes, nonpowered anoscopes, binolcular attachments for endoscopes, pocket battery boxes, flexible or rigid choledochoscopes, colonoscopes, diagnostic cystoscopes, cystourethroscopes, enteroscopes, esophagogastroduodenoscopes, rigid esophagoscopes, fiberoptic illuminators for endoscopes, incandescent endoscope lamps, biliary pancreatoscopes, proctoscopes, resectoscopes, nephroscopes, sigmoidoscopes, ureteroscopes, urethroscopes, endomagnetic retrievers, cytology brushes for endoscopes, and lubricating jelly for transurethral surgical instruments. This section does not apply to endoscopes that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.(b)
Classification —(1)Class II (special controls). The device, when it is an endoscope disinfectant basin, which consists solely of a container that holds disinfectant and endoscopes and accessories; an endoscopic magnetic retriever intended for single use; sterile scissors for cystoscope intended for single use; a disposable, non-powered endoscopic grasping/cutting instrument intended for single use; a diagnostic incandescent light source; a fiberoptic photographic light source; a routine fiberoptic light source; an endoscopic sponge carrier; a xenon arc endoscope light source; an endoscope transformer; an LED light source; or a gastroenterology-urology endoscopic guidewire, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I for the photographic accessories for endoscope, miscellaneous bulb adapter for endoscope, binocular attachment for endoscope, eyepiece attachment for prescription lens, teaching attachment, inflation bulb, measuring device for panendoscope, photographic equipment for physiologic function monitor, special lens instrument for endoscope, smoke removal tube, rechargeable battery box, pocket battery box, bite block for endoscope, and cleaning brush for endoscope. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807of this chapter, subject to the limitations in § 876.9.